sorbitol has been researched along with Tumor Lysis Syndrome in 1 studies
D-glucitol : The D-enantiomer of glucitol (also known as D-sorbitol).
Tumor Lysis Syndrome: A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ficorella, C | 1 |
1 other study available for sorbitol and Tumor Lysis Syndrome
| Article | Year |
|---|---|
[Metabolic emergencies in oncology: the tumor lysis syndrome].
Topics: Allopurinol; Bicarbonates; Calcium Gluconate; Diuresis; Emergencies; Humans; Renal Dialysis; Sorbito | 1994 |